Skip to main content

Table 1 Immunohistochemical profile of EGFR IHC staining in 653 triple negative breast tumours

From: Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy

EGFR IHC staining

Number of cases (Percentage)

Negative (0)

455 (70%)

Weak (1+)

159 (24%)

Moderate (2+)

24 (4%)

Strong (3+)

15 (2%)

Total

653 (100%)

  1. IHC, immunohistochemical.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us